510(k) Report

510(k) · Cleared

Cleared

RESIN 11

K121170510(k) TraditionalCleared Jul 13, 201287-day reviewClass II21 CFR 868.5665

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Respinnovation Sas · BYI Percussor, Powered-Electric

Cleared on Jul 13, 2012 as substantially equivalent to K024309 (Advanced Respiratory, 2003) after an 87-day review. Its family tree reaches back 5 generations to 1988.

Decided
Jul 13, 2012
Review
87 days
Class
Class II
Product code
BYI
Recalls
None
Predicates
1

Its longest line of descent runs back 5 generations to K884098 (1988). No later device cites it as a predicate yet.

  1. Root · 5 generations backK884098 Thairapy (TM) Bronchial Drainage System, Model 101American Biosystems, Inc. · 1988
  2. 4 generations backK965192 Thairapy Vest SystemAmerican Biosystems, Inc. · 1997
  3. 3 generations backK993629 Abi Vest Airway Clearance SystemAmerican Biosystems, Inc. · 2000
  4. 2 generations backK012928 Abi Vest Airway Clearance SystemAdvanced Respiratory · 2001
  5. 1 generation backK024309 The Vest Airway Clearance System, Model 104Advanced Respiratory · 2003
  6. This deviceK121170 RESIN 11Respinnovation Sas · 2012
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−5K884098Thairapy (TM) Bronchial Drainage System, Model 101American Biosystems, Inc.1988—
−4K965192Thairapy Vest SystemAmerican Biosystems, Inc.1997—
−3K993629Abi Vest Airway Clearance SystemAmerican Biosystems, Inc.2000—
−2K012928Abi Vest Airway Clearance SystemAdvanced Respiratory2001—
−1K024309The Vest Airway Clearance System, Model 104Advanced Respiratory2003—
0 (this device)K121170RESIN 11Respinnovation Sas2012—
FIG. 1 — Lineage of K121170, 1988–2012Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in BYI? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new BYI device

  1. #1 K252849 AffloVest® Mobile Airway Clearance Therapyscore 12.5 · 5 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K024309The Vest Airway Clearance System, Model 104
Summary page 1
…CFR 868.5 665 Class 11 Device: RespIlI Predicate Device: Advanced Respiratory -The Vest K024309 Device Description: Resplnl I is a medical device developed for an effective therapy of airway obstruction conditions. The devic…
Advanced Respiratory2003—

Also cleared against K024309: 3 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 24 years and passes through 3 companies; a new generation was cleared every 2.6 years on median.
  • None of the 5 ancestors has a recall.
  • 3 other devices also cite its predicate K024309.

How does its category compare?

All BYI devices

BYI Percussor, Powered-Electric: FDA decisions, review times, recalls and adverse event reports over 20 years. 2012, this device’s year, is highlighted.

FDA decisions per year · BYI

1in 2025

2007: 12010: 12011: 12012: 12013: 32015: 12017: 12018: 12021: 22022: 12024: 32025: 12026 (partial year): 1
2007high 3 (2013) · low 0 (2008)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · BYI

157in 2024

2013: 225 days median2024: 157 days median
2007high 225 (2013) · low 157 (2024)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · BYI

1in 2017

2014: 12017: 1
2007high 1 (2014) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · BYI

38in 2025

2007: 82008: 52009: 82010: 72011: 172012: 82013: 62014: 102015: 42016: 42017: 42018: 92019: 62020: 42021: 152022: 162023: 92024: 192025: 38
2007high 38 (2025) · low 4 (2015)2025

MAUDE reports naming product code BYI, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—08
20080—05
20090—08
20101—07
20111—017
20121—08
2013322506
20140—110
20151—04
20160—04
20171—14
20181—09
20190—06
20200—04
20212—015
20221—016
20230—09
20243157019
20251—038
20261—0—

What is it indicated for?

The Resplni 1 is intended to provide airway clearance therapy when external manipulation of the thorax is the physician's choice of treatment. Indications for this form of therapy are described by the American Association for Respiratory Care (AARC) in the Clinical Practices Guidelines for Postural Drainage Therapy' (1991). According to AARC guidelines, specific indications for external manipulation of the thorax include evidence or a suggestion of…

Read the full statement (118 words)

The Resplni 1 is intended to provide airway clearance therapy when external manipulation of the thorax is the physician's choice of treatment. Indications for this form of therapy are described by the American Association for Respiratory Care (AARC) in the Clinical Practices Guidelines for Postural Drainage Therapy' (1991). According to AARC guidelines, specific indications for external manipulation of the thorax include evidence or a suggestion of retained secretions, evidence that the patient is having difficulty with the secretion clearance, or presence of atelectasis caused by mucus plugging. In addition, the Respin I I is also indicated for external manipulation of the thorax to promote airway clearance or improve bronchial drainage for purposes of collecting mucus for diagnostic evaluation.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K121170: RESIN 11.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K121170

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026